Pages that link to "Q68943952"
Jump to navigation
Jump to search
The following pages link to [Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo] (Q68943952):
Displaying 9 items.
- Serenoa repens for benign prostatic hyperplasia (Q24202555) (← links)
- Serenoa repens for benign prostatic hyperplasia (Q24241144) (← links)
- Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review (Q27015007) (← links)
- Pharmacological effects of saw palmetto extract in the lower urinary tract (Q37406930) (← links)
- Serenoa repens (saw palmetto): a systematic review of adverse events (Q37547218) (← links)
- Randomized double-blind controlled clinical trials with herbal preparations of Serenoa repens fruits in treatment of lower urinary tract symptoms : An overview (Q39024174) (← links)
- Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia (Q41217704) (← links)
- A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia. (Q53243983) (← links)
- Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract of Serenoa repens (Permixon) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-beta-sitosterol (Q73406050) (← links)